Comparison of Immunogenicity and Safety between a Single Dose and One Booster Trivalent Inactivated Influenza Vaccination in Patients with Chronic Kidney Disease: A 20-Week, Open-Label Trial

Background: Non-dialysis-dependent chronic kidney disease (CKD-ND) patients are recommended to receive a one-dose influenza vaccination annually. However, studies investigating vaccine efficacy in the CKD-ND population are still lacking. In this study, we aimed to evaluate vaccine efficacy between t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Yu-Tzu, Ling, Tsai-Chieh, Cheng, Ya-Yun, Sun, Chien-Yao, Wu, Jia-Ling, Tai, Ching Hui, Wang, Jen-Ren, Sung, Junne-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996510/
https://www.ncbi.nlm.nih.gov/pubmed/33669067
http://dx.doi.org/10.3390/vaccines9030192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996510/
https://www.ncbi.nlm.nih.gov/pubmed/33669067
http://dx.doi.org/10.3390/vaccines9030192

Ejemplares similares